Tonix Pharmaceuticals
TNXP
#8331
Rank
S$0.29 B
Marketcap
S$25.34
Share price
-0.61%
Change (1 day)
-5.65%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2025 (TTM): -S$0.13 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are S$10.29 Million. In 2024 the company made an earning of -S$97.05 Million, an increase over its 2023 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.13 Billion29.38%
2024 -S$97.05 Million-36.5%
2023 -S$0.16 Billion5.61%
2022 -S$0.15 Billion21.43%
2021 -S$0.12 Billion82.76%
2020 -S$65.21 Million75.22%
2019 -S$37.22 Million9.52%
2018 -S$33.99 Million23.63%
2017 -S$27.49 Million-45.36%
2016 -S$50.31 Million-19.09%
2015 -S$62.18 Million74.15%
2014 -S$35.71 Million153.99%
2013 -S$14.06 Million
2011 -S$6.79 Million29538.74%
2010 -S$0.03 Million-42.58%
2009 -S$0.04 Million46.05%
2008 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-S$30.01 Million-75.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
S$46.03 M-137.16%๐Ÿ‡บ๐Ÿ‡ธ USA